November 19th, 2026Podcast: NIH Team Details Path From Ketamine Metabolite Discovery to Phase 2 Trials2R,6R-HNK reproduces ketamine’s rapid antidepressant profile in rodents without dissociation or abuse signals, and is now in four phase 2 trials.Read more
November 6th, 2026Podcast: Interventional Psychiatry and the Challenge of Difficult-to-Treat DepressionLisa Harding, MD, says ECT, ketamine, TMS, and VNS can work, but evidence on what comes after acute response remains thin.Read more